Drug recall D-1566-2020
Product
Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-4177-73.
Reason for recall
Sub-Potent Drug: Out of specification test results for potency (below specification).
Lots and codes
Lot #: 30310638A, Exp. 02/2022
Recall details
- Recalling firm
- Teva Pharmaceuticals USA, Parsippany, NJ
- Quantity
- 38,487 bottles
- Distribution
- Nationwide in the U.S. and Puerto Rico.
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 24, 2020
- Terminated
- December 16, 2021
Related products
- Cephalexin – drug information
- NDC 0093-4177 Cephalexin · Cephalexin 250 mg/5mL · Teva Pharmaceuticals USA, Inc.
- NDC 0093-4175 Cephalexin · Cephalexin 125 mg/5mL · Teva Pharmaceuticals USA, Inc.
- NDC 0093-3145 Cephalexin · Cephalexin 250 mg/1 · Teva Pharmaceuticals USA, Inc.
- NDC 0093-3147 Cephalexin · Cephalexin 500 mg/1 · Teva Pharmaceuticals USA, Inc.